Milton Haber
Internal Medicine · Laredo, TXNPI 1205983202
Payments from drug & device makers
Across 751 payments — averaging $14,269 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$9.4M
- Pfizer$1.3M
- Gilead$23K
- Novo Nordisk AS$19K
- Merck$9K
What the payments were for
- Food & beverage$76100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 417 | $9,412,346 |
| Pfizer | 78 | $1,252,774 |
| Gilead | 3 | $22,864 |
| Novo Nordisk AS | 250 | $19,446 |
| Merck | 3 | $8,512 |
How this compares
$10,715,943 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Laredo
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.